Products
Ventora Airway Pressure Monitor
The Ventora Airway Pressure Monitor is designed to provide accurate and continuous monitoring of airway pressure in neonatal and infant patients receiving non-invasive respiratory support. Ventora's innovative device will enable precise monitoring without adding invasiveness to treatment or altering clinical workflows.
By delivering continuous and objective feedback, the Ventora Airway Pressure Monitor will support clinicians in their decision making and empower them to deliver proactive and optimised respiratory care. ​
Disclaimer: The device is still currently under development.
A new level of insight in neonatal respiratory support
.png)
Objective data to support proactive decisions
Real-time airway pressure data to help clinicians make informed, timely decisions.
Promote consistent CPAP and HFNC pressure delivery
Helps clinicians control delivered airway pressure to support effective respiratory care.
Designed to integrate seamlessly into existing treatment practices
Compatible with all CPAP and HFNC systems and fits seamlessly into current clinical workflows.
Align with respiratory care best practice
Supports adherence to AARC guidelines and manufacturers' instructions for pressure monitoring.
Key Features​​
Continuous monitoring
Accurate and continuous monitoring of the delivered airway pressure by CPAP and nasal high flow.
Compatible with all CPAP and HFNC systems
Device can be used with all non-invasive respiratory support systems, including CPAP and nasal high flow.
Internal airway pressure measurement
Measures pressure within the airway, while competitor products measure pressure in the respiratory circuit, external to the patient.
User-defined alarms
User-defined alarms alert clinicians and nurses when under- and over-pressure events occur. User settings prevent alarm fatigue.
Dual-functionality
Dual-function device enables enteral feeding in addition to airway pressure monitoring to streamline care.
Why monitor airway pressures delivered by CPAP and nasal high flow?
Neonatal respiratory distress affects about 7% of all newborns, primarily affecting premature infants due to their underdeveloped lungs.​ Non-invasive respiratory support methods such as continuous positive airway pressure (CPAP) and high flow nasal cannula (HFNC) are often the first choice of treatment for neonatal respiratory distress. However, studies have found that there is significant variability in the pressures delivered to patients' airways by these systems. Clinicians currently have no accurate measurement of the pressure that is delivered to the airways by CPAP and HFNC.
This results in:
.png){kind=small}
Time-consuming troubleshooting
Nurses spend considerable time troubleshooting CPAP and HFNC to ensure that patients consistently receive the prescribed support.
No consensus
There remains no clear consensus on the ideal level of CPAP or the optimal strategy to wean or discontinue therapy.
Inconsistent failure rates
CPAP and HFNC failure rates (reported between 20-40%) remain highly variable between units due to differences in clinical practice.
​“We don’t know what pressure is actually being delivered.”
​
- Neonatologist
“We are currently making decisions on best-guessed data.”
​
- Neonatologist
​​
“A baby will open their mouth and suddenly you lose all that pressure.”
​
- NICU Respiratory Manager
